Genetic testing for mutations in BRCA1 and BRCA2 has potentially important health implications as physicians could offer risk-reducing options such as prophylactic mastectomy and oophorectomy, tamoxifen, as well as specialized surveillance programs for mutation carriers who have not yet developed cancer, as well as targeted cancer therapies for women with BRCA-associated cancer [7-11]. Here, BRCA1 is linked to cancer.